ESTIMATES OF CARDIOVASCULAR RISK REDUCTION WITH NIACIN EXTENDED-RELEASE AND SIMVASTATIN IN MIXED DYSLIPIDEMIA

被引：0
作者：
Insull, W. [1 ]
Jiang, P. [2 ]
Tian, M. [2 ]
Thakkar, R. [2 ]
Padley, R. [2 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Abbott, Abbott Pk, IL USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2009年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
[41]   Effects of co-administered extended release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia [J].
Ballanlyne, Christie ;
Gleim, Gilbert ;
Mitchel, Yale ;
Thompson-Bell, Sally ;
Liu, Nancy ;
Johnson-Levonas, Amy ;
Paolini, John F. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) :A325-A326
[42]   Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy [J].
Insull, William, Jr. ;
Toth, Peter P. ;
Superko, H. Robert ;
Thakkar, Roopal B. ;
Krause, Scott ;
Jiang, Ping ;
Parreno, Rhea A. ;
Padley, Robert J. .
VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 :1065-1075
[43]   Relative safety of extended-release niacin versus other niacin formulations [J].
Alsheikh-Ali, AA ;
Abourjaily, HM ;
Kares, RH .
CIRCULATION, 2004, 110 (17) :813-814
[44]   Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH [J].
Goldberg, Ronald B. ;
Bittner, Vera A. ;
Dunbar, Richard L. ;
Fleg, Jerome L. ;
Grunberger, George ;
Guyton, John R. ;
Leiter, Lawrence A. ;
McBride, Ruth ;
Robinson, Jennifer G. ;
Simmons, Debra L. ;
Wysham, Carol ;
Xu, Ping ;
Boden, William E. .
AMERICAN JOURNAL OF MEDICINE, 2016, 129 (07) :753.e13-753.e22
[45]   Extended-release niacin with or without inhibitors of hydroxymethylglutaryl CoA reductase: Improvement in dyslipidemia with minimal effect on transaminases [J].
Guyton, JR ;
OConnor, CM ;
Goldberg, AC ;
Kreisberg, RA ;
Sprecher, DL ;
Superko, HR .
ATHEROSCLEROSIS, 1997, 134 (1-2) :56-56
[46]   Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacin [J].
LaFleur, Joanne ;
Thompson, Clinton J. ;
Joish, Vijay N. ;
Charland, Scott L. ;
Oderda, Gary M. ;
Brixner, Diana I. .
ANNALS OF PHARMACOTHERAPY, 2006, 40 (7-8) :1274-1279
[47]   Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia - The OCEANS study [J].
Karas, Richard H. ;
Kashyap, Moti L. ;
Knopp, Robert H. ;
Keller, Laurence H. ;
Bajorunas, Daiva R. ;
Davidson, Michael H. .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2008, 8 (02) :69-81
[48]   Extended-release Niacin Acutely Suppresses Postprandial Triglyceridemia [J].
Usman, M. Haris U. ;
Qamar, Arman ;
Gadi, Ramprasad ;
Lilly, Scott ;
Goel, Harsh ;
Hampson, Jaison ;
Mucksavage, Megan L. ;
Nathanson, Grace A. ;
Rader, Daniel J. ;
Dunbar, Richard L. .
AMERICAN JOURNAL OF MEDICINE, 2012, 125 (10) :1026-1035
[49]   Effects of extended-release niacin on lipoprotein subclass distribution [J].
Morgan, JM ;
Capuzzi, DM ;
Baksh, RI ;
Intenzo, C ;
Carey, CM ;
Reese, D ;
Walker, K .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (12) :1432-1436
[50]   Modeled achievement of optimal lipid values with extended-release niacin/lovastatin versus simvastatin/ezetimibe combination therapy in at-risk patients [J].
Stanek, EJ ;
Quimbo, R ;
Cziraky, MJ ;
Charland, SL .
VALUE IN HEALTH, 2006, 9 (03) :A120-A120
12345